South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

South and Central America In Vitro Diagnostics3.2 Clinical Chemistry
Investment Opportunities, Analysis and Forecasts3.3 Genetic Testing
to 20153.4 Haematology
Summary3.5 Histology And Cytology
This report is an essential source for in-depth3.6 Immuno Chemistry
information and data relating to South &3.7 Infectious Immunology
Central America In vitro diagnostics market. It3.8 Microbiology Culture 4 In Vitro Diagnostics in
also offers detailed and comprehensive coverageSouth and Central America
of market revenue, distribution and company4.1 In Vitro Diagnostics, South and Central
share information; and the latest news, financialAmerica, Overall Revenue ($ mn), 2000-2015
deals and pipeline products information of each of4.2 In Vitro Diagnostics, South and Central
the key sub-segments of the in vitro diagnosticsAmerica, Company share (2007-2008) 5 In Vitro
market in South & Central America.Diagnostics In Brazil
Scope5.1 In Vitro Diagnostics, Brazil, Overall Revenue ($
The report provides information on the South andmn), 2000-2015
Central American in vitro diagnostics market,5.2 In Vitro Diagnostics, Brazil, Distribution Share
broken down into detailed categories and(2007-2008)
segments including In Vitro Diagnostics Devices,5.2.1 Clinical Chemistry Distribution Share
Clinical Chemistry Test Reagents,(2007-2008)
Immunochemistry Test Reagents, Blood Test5.2.2 Genetic Testing Distribution Share
Reagents, Microbiology Test Reagents, Infectious(2007-2008)
Immunology Test Reagents, Genetic Test5.2.3 Haematology Distribution Share (2007-2008)
Reagents, Self Testing, and Instruments.5.2.4 Histology And Cytology Distribution Share
Market shares of all the key competitors including(2007-2008)
F. Hoffmann-La Roche Ltd., Abbott Laboratories,5.2.5 Immuno Chemistry Distribution Share
Beckman Coulter, Inc., and Siemens Medical(2007-2008)
Solutions, amongst others.5.2.6 Infectious Immunology Distribution Share
Key pipeline products that are set to shape the(2007-2008)
market, broken down by sector.5.2.7 Microbiology Culture Distribution Share
Information on the top medical equipment(2007-2008)
companies in the sector in the country covering5.3 In Vitro Diagnostics, Brazil, Company Share
business description, strategic analysis.(2007-2008)
Healthcare structure, regulatory environment,5.3.1 In Vitro Diagnostics, Brazil, Company Share
approval process, pricing trends and(2007-2008)
reimbursement.5.3.2 Clinical Chemistry, Brazil, Company Share
Product and brand updates, strategy changes,(2007-2008)
R&D projects, corporate expansions and5.3.3 Genetic Testing, Brazil, Company Share
contractions and regulatory changes.(2007-2008)
Key mergers and acquisitions, partnerships,5.3.4 Haematology, Brazil, Company Share
private equity investments and IPOs.(2007-2008)
Customer, hospitals and physicians data. 1 Table5.3.5 Histology And Cytology, Brazil, Company
of ContentsShare (2007-2008)
1.1 List of Tables5.3.6 Immuno Chemistry, Brazil, Company Share
1.2 List of Figures 2 Introduction(2007-2008)
2.1 What Is This Report About? 3 Definitions of5.3.7 Infectious Immunology, Brazil, Company
Markets Covered in the ReportShare (2007-2008)
3.1 In Vitro Diagnostics5.3.